Alzheimer's disease and down syndrome: From meiosis to dementia

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 403-413

  Petronis, Arturas ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Aberration of meiotic recombination; Aging; Alzheimer's disease; Chromosome 21; Complex genetic disease; Down syndrome; Epigenetics; Genetic risk factors

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 21; CHROMOSOME DISORDER; DEMENTIA; DOWN SYNDROME; FRAGILE X SYNDROME; GENETIC RISK; HUMAN; HUNTINGTON CHOREA; MATERNAL AGE; MEIOSIS; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; SEX CHROMOSOME; TRISOMY 21;

EID: 0032816455     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7128     Document Type: Article

References (113)

1. Amaducci L. A., Fratiglioni L., Rocca W. A., Fieschi C., Livrea P., Pedone D., Bracco L., Lippi A., Gandolfo C., Bino G., Prencipe M., Bonatti M. L., Girotti F., Carella F., Tavolato B., Ferla S., Lenzi G. L., Carolei A., Gambi A., Grigoletto F., Schoenberg B. S. Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology. 36:1986;922-931.
2. Berr C., Borghi E., Rethore M. O., Lejeune J., Alperovitch A. Absence of familial association between dementia of Alzheimer type and Down syndrome. Am. J. Med. Genet. 33:1989;545-550.
3. Berr C., Okra-Podrabinek N., Feteanu D., Taurand S., Hervy M. P., Forette F., Piette F., Sebag-Lanoe R., Alperovitch A. Dermatoglyphic patterns in dementia of the Alzheimer type: A case-control study. J. Epidemiol. Community Health. 46:1992;512-516.
4. Beyreuther K., Pollwein P., Multhaup G., Monning U., Konig G., Dyrks T., Schubert W., Masters C. L. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann. N. Y. Acad. Sci. 695:1993;91-102.
5. Broe G. A., Henderson A. S., Creasey H., McCusker E., Korten A. E., Jorm A. F., Longley W., Anthony J. C. A case-control study of Alzheimer's disease in Australia. Neurology. 40:1990;1698-1707.
6. Brown W. T. The molecular biology of the fragile X mutation. Hagerman R. J., Silverman A. C. Fragile X Syndrome: Diagnosis, Treatment and Research. 1991;146-172 Johns Hopkins Univ. Press, Baltimore.
7. Brunner H. G., Smeets H., Lambermon H. M. M., Coerwinkel-Driessen M., van Oost B. A., Wieringa B., Ropers H. H. A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19. Genomics. 5:1989;589-595.
8. Buckland P., Tidmarsh S., Spurlock G., Kaiser F., Yates M., O'Mahony G., McGuffin P. Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. Brain Res. Mol. Brain Res. 18:1993;316-320.
9. Buetow K. H., Shiang R., Yang P., Nakamura Y., Lathrop M. G., White R., Wasmuth J. J., Wood S., Berdahl L. D., Leysens N. J., Ritty T. M., Wise M. E., Murray J. C. A detailed multipoint map of human chromosome 4 provides evidence for linkage heterogeneity and position-specific recombination rates. Am. J. Hum. Genet. 48:1991;911-925.
10. Burt D. B., Loveland K. A., Lewis K. R. Depression and the onset of dementia in adults with mental retardation. Am. J. Ment. Retard. 96:1992;502-511.
11. Cork L. C. Neuropathology of Down syndrome and Alzheimer disease. Am. J. Med. Genet. (Suppl.). 7:1990;282-286.
12. Davies G. E., Howard C. M., Farrer M. J., Coleman M. M., Bennett L. B., Cullen L. M., Wyse R. K., Burn J., Williamson R., Kessling A. M. Genetic variation in the COL6A1 region is associated with congenital heart defects in trisomy 21(Down's syndrome). Ann. Hum. Genet. 59:1995;253-269.
13. Davies P. The genetics of Alzheimer's disease: A review and a discussion of the implications. Neurobiol. Aging. 7:1986;459-466.
14. Delabar J. M., Goldgaber D., Lamour Y., Nicole A., Huret J. L., de Grouchy J., Brown P., Gajdusek D. C., Sinet P. M. Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science. 13:1987;1390-1392.
15. Detera-Wadleigh S. D., Badner J. A., Goldin L. R., Berrettini W. H., Sanders A. R., Rollins D. Y., Turner G., Moses T., Haerian H., Muniec D., Nurnberger J. I. Jr., Gershon E. S. Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q. Am. J. Hum. Genet. 58:1996;1279-1285.
16. Dickson D. W. Neuropathological diagnosis of Alzheimer's disease: A perspective from longitudinal clinicopathological studies. Neurobiol. Aging Suppl. 18:1997;S21-S26.
17. Epstein C. J. Down syndrome. Rosenberg R. N., Prusiner S. B., DiMauro S., Barchi R. L., Kunkel L. M. The Molecular and Genetic Basis of Neurological Disease. 1993;49-78 Butterworth-Heinemann, Stoneham.
18. Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., van Duijn C. M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis - APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 278:1997;1349-1356.
19. Farrer M. J., Crayton L., Davies G. E., Oliver C., Powell J., Holland A. J., Kessling A. M. Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome. NeuroReport. 8:1997;1645-1649.
20. Franceschi M., Comola M., Piattoni F., Gualandri W., Canal N. Prevalence of dementia in adult patients with trisomy 21. Am. J. Med. Genet. 7:1990;306-308.
21. Gaulden M. E. Maternal age effect: The enigma of Down syndrome and other trisomic conditions. Mutat. Res. 296:1992;69-88.
22. Genet. Epidemiol. 10:1993.
23. Glenner G. G., Wong C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
24. Glenner G. G., Wong C. W. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122:1984;1131-1135.
25. Goate A. M., Haynes A. R., Owen M. J., Farrall M., James L. A., Lai L. Y. C., Mullan M. J., Roques P., Rossor M. N., Williamson R., Hardy J. A. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet. 8634:1989;352-355.
26. Godde J. S., Wolffe A. P. Nucleosome assembly on CTG triplet repeats. J. Biol. Chem. 271:1996;15222-15229.
27. Godde J. S., Kass S. U., Hirst M. C., Wolffe A. P. Nucleosome assembly on methylated CGG triplet repeats in the fragile X mental retardation gene 1 promoter. J. Biol. Chem. 271:1996;24325-24328.
28. Goldgaber D., Lerman M. I., McBride O. W., Saffiotti U., Gajdusek D. C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
29. Govoni S., Bergamaschi S., Gasparini L., Quaglia C., Racchi M., Cattaneo E., Binetti G., Bianchetti A., Giovetti F., Battaini F., Trabuechi M. Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation. Neurology. 47:1996;1069-1075.
30. Haass C. Presenile because of presenilin: The presenilin genes and early onset Alzheimer's disease. Curr. Opin. Neurol. 9:1996;254-259.
31. Hardy J. The Alzheimer family of diseases: Many etiologies, one pathogenesis. Proc. Natl. Acad. Sci. USA. 94:1997;2095-2097.
32. Heston L. L., Mastri A. R., Anderson V. E., White J. Dementia of the Alzheimer type: Clinical genetics, natural history, and associated conditions. Arch. Gen. Psychiat. 38:1981;1085-1090.
33. Heston L. L., Orr H. T., Rich S. S., White J. A. Linkage of an Alzheimer disease susceptibility locus to markers on human chromosome 21. Am. J. Med. Genet. 40:1991;449-453.
34. Hewitt K. E., Carter G., Jancar J. Ageing in Down's syndrome. Br. J. Psychiat. 147:1985;58-62.
35. Heyman A., Wilkinson W. E., Hurwitz B. J., Schmechel D., Sigmon A. H., Weinberg T., Helms M. J., Swift M. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann. Neurol. 14:1983;507-515.
36. Holtzman D. M. Alzheimer disease and Down syndrome. Cytogenet. Cell Genet. 77:1997;17.
37. Howard C. M., Davies G. E., Farrer M. J., Cullen L. M., Coleman M. M., Williamson R., Wyse R. K., Palmer R., Kessling A. M. Meiotic crossing-over in nondisjoined chromosomes of children with trisomy 21 and a congenital heart defect. Am. J. Hum. Genet. 53:1993;462-471.
38. Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., Hyman B. T. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
39. Johannsen P., Christensen J. E., Mai J. The prevalence of dementia in Down syndrome. Dementia. 7:1996;221-225.
40. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
41. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W. S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M. C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., Owen M. J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8:1999;237-245.
42. Koehler K. E., Hawley R. S., Sherman S., Hassold T. Recombination and nondisjunction in humans and flies. Hum. Mol. Genet. 5:1996;1495-1504.
43. Korenberg J. R., Chen X.-N., Schipper R., Sun Z., Gonsky R., Gerwehr S., Carpenter N., Daumer C., Dignan P., Disteche C., Graham J. M. Jr., Hugdins L., McGillivray B., Miyazaki K., Ogasawara N., Park J. P., Pagon R., Pueschel S., Sack G., Say B., Schuffenhauer S., Soukup S., Yamanaka T. Down syndrome phenotypes: The consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. USA. 91:1994;4997-5001.
44. Korneluk R. G., MacKenzie A. E., Nakamura Y., Dube I., Jacob P., Hunter A. G. W. A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus. Genomics. 5:1989;596-604.
45. Lamb N. E., Freeman S. B., Savage-Austin A., Pettay D., Taft L., Hersey J., Gu Y., Shen J., Saker D., May K. M., Avramopoulos D., Petersen M. B., Hallberg A., Mikkelsen M., Hassold T. J., Sherman S. L. Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nature Genet. 14:1996;400-405.
46. Leverenz J. B., Raskind M. A. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis. Exp. Neurol. 150:1998;296-304.
47. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y. H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
48. Li G., Shen Y. C., Li Y. T., Chen C. H., Zhau Y. W., Silverman J. M. A case-control study of Alzheimer's disease in China. Neurology. 42:1992;1481-1488.
49. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 90:1997;917-927.
50. Liddell M. B., Bayer A. J., Owen M. J. No evidence that common allelic variation in the amyloid precursor protein (APP) gene confers susceptibility to Alzheimer's disease. Hum. Mol. Genet. 4:1995;853-858.
51. Lorda-Sanchez I., Binkert F., Maechler M., Robinson W. P., Schinzel A. A. Reduced recombination and paternal age effect in Klinefelter syndrome. Hum. Genet. 89:1992;524-530.
52. Luxenberg J. S., Plato C. C., Fox K. M., Friedland R. P., Rapoport S. I. Digital and palmar dermatoglyphics in dementia of the Alzheimer type. Am. J. Med. Genet. 30:1988;733-740.
53. MacDonald M. E., Haines J. L., Zimmer M., Cheng S. V., Youngman S., Whaley W. L., Wexler N., Bucan M., Allito B. A., Smith B., Leavitt J., Poustka A., Harper P., Lehrach H., Wasmuth J. J., Frischauf A.-M., Gusella J. F. Recombination events suggest potential sites for the Huntington's disease gene. Neuron. 3:1989;183-190.
54. MacDonald M., Hassold T., Harvey J., Wang L. H., Morton N. E., Jacobs P. The origin of 47,XXY and 47,XXX aneuploidy: Heterogeneous mechanisms and role of aberrant recombination. Hum. Mol. Genet. 3:1994;1365-1371.
55. Mann D. M. Cerebral amyloidosis, ageing and Alzheimer's disease: A contribution from studies on Down's syndrome. Neurobiol. Aging. 10:1989;397-399.
56. Mendez M. F., Underwood K. L., Zander B. A., Mastri A. R., Sung J. H., Frey W. H. Risk factors in Alzheimer's disease: A clinicopathologic study. Neurology. 42:1992;770-775.
57. Morrison-Bogorad M., Rosenberg R. N., Sparkman D. R., Weiner M. F., White C. L. III. Alzheimer's disease. Rosenberg R. N., Prusiner S. B., DiMauro S., Barchi R. L., Kunkel L. M. The Molecular and Genetic Basis of Neurological Disease. 1993;767-780 Butterworth-Heinemann, Stoneham.
58. Nee L. E., Polinsky R. J., Eldridge R., Weingartner H., Smallberg S., Ebert M. A family with histologically confirmed Alzheimer's disease. Arch. Neurol. 40:1983;203-208.
59. Okra Podrabinek N., Roudier M., Lamour Y., de Grouchy J. Dermatoglyphic patterns in senile dementia of Alzheimer's type. Ann. Genet. 31:1988;91-96.
60. Oliver C., Holland A. J. Down's syndrome and Alzheimer's disease: A review. Psychol. Med. 16:1986;307-322.
61. Pallister C., Jung S. S., Shaw I., Nalbantoglu J., Gauthier S., Cashman N. R. Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging. Neurobiol. Aging. 18:1997;97-103.
62. Pericak-Vance M. A., Yamaoka L. H., Haynes C. S., Speer M. C., Haines J. L., Gaskell P. C., Hung W. Y., Clark C. M., Heyman A. L., Trofatter J. A., Eisenmenger J. P., Gilbert J. R., Lee J. E., Alberts M. J., Dawson D. V., Bartlett R. J., Earl N. L., Siddique T., Vance J. M. Genetic linkage studies in Alzheimer's disease families. Exp. Neurol. 102:1988;271-279.
63. Pericak-Vance M. A., Haines J. L. Genetic susceptibility to Alzheimer disease. Trends Genet. 11:1995;504-508.
64. Petronis A. Genomic imprinting in unstable DNA diseases. BioEssays. 18:1996;587-590.
65. Podlisny M. B., Lee G., Selkoe D. J. Gene dosage of the amyloid beta precursor protein in Alzheimer's disease. Science. 238:1987;669-671.
66. Popper K. R. Conjectures and Refutations: The Growth of Scientific Knowledge. 1963;Basic Books, New York.
67. Potter H. Review and hypothesis: Alzheimer disease and Down syndrome - Chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet. 48:1991;1192-1200.
68. Pueschel S. M., Louis S., McKnight P. Seizure disorders in Down syndrome. Arch. Neurol. 48:1991;318-320.
69. Rocca W. A., van Duijn C. M., Clayton D., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A., Shalat S. L., Soininen H., Hofman A. Maternal age and Alzheimer's disease: A collaborative re-analysis of case-control studies - EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:1991;S21-S27.
70. Romano, C., A. Tine, G. Fazio, R. Rizzo, R. M. Colognola, G. Sorge, P. Bergonzi, and L. Pavone. Seizures in patients with trisomy 21. Am. J. Med. Genet. Suppl.7: 298-300.
71. Roses A. D. Apolipoprotein E in neurology. Curr. Opin. Neurol. 9:1996;265-270.
72. Sadovnick A. D., Yee I. M., Hirst C. The rate of the Down syndrome among offspring of women with Alzheimer disease. Psychiatr. Genet. 4:1994;87-89.
73. Schellenberg G. D., Bird T. D., Wijsman E. M., Moore D. K., Boehnke M., Bryant E. M., Lampe T. H., Nochlin D., Sumi S. M., Deeb S. S., Beyreuther K., Martin G. M. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science. 241:1988;1507-1510.
74. Schellenberg G. D., Pericak-Vance M. A., Wijsman E. M., Moore D. K., Gaskell P. C. Jr., Yamaoka L. A., Bebout J. L., Anderson L., Welsh K. A., Clark C. M., Martin G. M., Roses A. D., Bird T. D. Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am. J. Hum. Genet. 48:1991;563-583.
75. Schupf N., Kapell D., Lee J. H., Ottman R., Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet. 344:1994;353-356.
76. Schweber, M.A possible unitary genetic hypothesis for Alzheimer's disease and Down syndrome. Ann. N. Y. Acad. Sci.450: 223-238.
77. Selkoe D. J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
78. Seltzer B., Sherwin I. Fingerprint pattern differences in early- and late-onset primary degenerative dementia. Arch. Neurol. 43:1986;665-668.
79. Sherman S. L., Takaesu N., Freeman S. B., Grantham M., Phillips C., Blackston R. D., Jacobs P. A., Cockwell A. E., Freeman V., Uchida I., Mikkelsen M., Kurnit D. M., Buraczynska M., Keats B. J. B., Hassold T. J. Trisomy 21: Association between reduced recombination and nondisjunction. Am. J. Hum. Genet. 49:1991;608-620.
80. Sherman S. L., Petersen M. B., Freeman S. B., Hersey J., Pettay D., Taft L., Frantzen M., Mikkelsen M., Hassold T. J. Non-disjunction of chromosome 21 in maternal meiosis. I. Evidence for a maternal age-dependent mechanism involving reduced recombination. Hum. Mol. Genet. 3:1994;1529-1535.
81. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., St-George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
82. Silverman J. M., Raiford K., Edland S., Fillenbaum G., Morris J. C., Clark C. M., Kukull W., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). VI. Family history assessment: A multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology. 44:1994;1253-1259.
83. Siniscalco M. Genetic recombination and disease. Cold Spring Harbor Symp. Quant. Biol. LI:1986;191-194.
84. Smith G. E., Berg J. M. Down's Anomaly. 1976;Churchill Livingstone, Edinburgh.
85. St. George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D., Growdon J., Bruni A., Foncin J.-F., Salmon D., Frommelt P., Amaducci L., Sorbi S., Piacentini S., Stewart G. D., Hobbs W. J., Conneally P. M., Gusella J. F. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 235:1987;885-890.
86. St. George-Hyslop P. H., Haines J. L., Farrer L. A., Polinsky R., Van Broeckhoven C., Goate A., McLachlan D. R., Orr H., Bruni A. C., Sorbi S., Rainero I., Foncin J. F., Pollen D., Cantu J. M., Tupler R., Voskresenskaya N., Mayeux R., Growdon J., Fried V. A., Meyers R. H., Nee L., Backhovens H., Martin J.-J., Rossor M., Owen M. J., Mullan M., Percy M. E., Karlinsky H., Rich S., Heston L., Montesi M., Mortilla M., Nacmias N., Gusella J. F., Hardy J. A. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder: FAD Collaborative Study Group. Nature. 347:1990;194-197.
87. St. George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J. F., Montesi M., Bruni A., Sorbi S., Rainero I., Pinessi L., Pollen D., Polinsky R., Nee L., Kennedy J., Macciardi F., Rogaeva E., Liang Y., Alexandrova N., Lukiw W., Schlumpf K., Tanzi R., Tsuda T., Farrer L., Cantu J.-M., Duara R., Amaducci L., Bergamini L., Gusella J., Roses A., Crapper-McLachlan D. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet. 2:1992;330-334.
88. St. George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Neve R. L., Pollen D., Drachman D., Growdon J., Cupples L. A., Nee L., Myers R. H., O'Sullivan D., Watkins P. C., Amos J. A., Deutsch C. K., Bodfish J. W., Kinsbourne M., Feldman R. G., Bruni A. B., Amaducci L., Foncin J. F. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science. 238:1987;664-666.
89. Straub R. E., Lehner T., Luo Y., Loth J. E., Shao W., Sharpe L., Alexander J. R., Das K., Simon R., Fieve R. R., Lerer B., Endicott J., Ott J., Gilliam T. C., Baron M. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nature Genet. 8:1994;291-296.
90. Tanzi R. E. Gene mutations in inherited amyloidopathies of the nervous system. Am. J. Hum. Genet. 49:1991;507-510.
91. Tanzi R. E., St. George-Hyslop P. H., Haines J. L., Polinsky R. J., Nee L., Foncin J.-F., Neve R. L., McClatchey A. I., Conneally P. M., Gusella J. F. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β protein gene. Nature. 329:1987;156-157.
92. Tanzi R. E., Bird E. D., Latt S. A., Neve R. L. The amyloid β protein gene is not duplicated in brains from patients with Alzheimer's disease. Science. 238:1987;666-669.
93. Tanzi R. E., Vaula G., Romano D. M., Mortilla M., Huang T. L., Tupler R. G., Wasco W., Hyman B. T., Haines J. L., Jenkins B. J., Kalaitsidaki M., Warren A. C., McInnis M. C., Antonarakis S. E., Karlinsky H., Percy M. E., Connor L., Growdon J., Crapper-McLachlan D. R., Gusella J. F., St. George-Hyslop P. H. Assessment of amyloid β protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51:1992;273-282.
94. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., St. George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
95. Tanzi R. E., Watkins P. C., Stewart G. D., Wexler N. S., Gusella J. F., Haines J. L. A genetic linkage map of human chromosome 21: analysis of recombination as a function of sex and age. Am. J. Hum. Genet. 50:1992;551-558.
96. Van Broeckhoven C., Genthe A. M., Vandenberghe A., Horsthemke B., Backhovens H., Raeymaekers P., Van Hul W., Wehnert A., Gheuens J., Cras P., Brulyand M., Martin J. J., Salbaum M., Multhaup G., Masters C. L., Beyreuther K., Gurling H. M. D., Mullan M. J., Holland A., Barton A., Irving N., Williamson R., Richards S. J., Hardy J. A. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature. 329:1987;153-155.
97. Van Broeckhoven C. L. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations. Eur. Neurol. 35:1995;8-19.
98. Van Duijn C. M., Clayton D., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A., Rocca W. A., Shalat S. L., Soininen H., Hofman A. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies - EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20:1991;S13-S20.
99. Van Duijn C. M., Clayton D. G., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A., Rocca W. A., Shalat S. L., Soininen H., Hofman A. Interaction between genetic and environmental risk factors for Alzheimer's disease: A reanalysis of case-control studies - EURODEM Risk Factors Research Group. Genet. Epidemiol. 11:1994;539-551.
100. Visser F. E., Aldenkamp A. P., van Huffelen A. C., Kuilman M., Overweg J., van Wijk J. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am. J. Ment. Retard. 101:1997;400-412.
101. Wang Y. H., Griffith J. Methylation of expanded CCG triplet repeat DNA from fragile X syndrome patients enhances nucleosome exclusion. J. Biol. Chem. 271:1996;22937-22940.
102. Wang Y. H., Amirhaeri S., Kang S., Wells R. D., Griffith J. D. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science. 265:1994;669-671.
103. Warren A. C., Chakravarti A., Wong C., Slaugenhaupt S. A., Halloran S. L., Watkins P. C., Metaxotou C., Antonarakis S. E. Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science. 237:1987;652-654.
104. Warren A. C., Robakis N. K., Ramakrishna N., Koo E. H., Ross C. A., Robb A. S., Folstein M. F., Price D. L., Antonarakis S. E. β-Amyloid gene is not present in three copies in autopsy-validated Alzheimer's disease. Genomics. 1:1987;307-312.
105. Warren A. C., Holroyd S., Folstein M. F. Major depression in Down's syndrome. Br. J. Psychiat. 155:1989;202-205.
106. Weber J. L., Wang Z., Hansen K., Stephenson M., Kappel C., Salzman S., Wilkie P. J., Keats B., Dracopoli N. C., Brandriff B. F., Olsen A. S. Evidence for human meiotic recombination interference obtained through construction of a short tandem repeat-polymorphism linkage map on chromosome 19. Am. J. Hum. Genet. 53:1993;1079-1095.
107. Weinreb H. J. Fingerprint patterns in Alzheimer's disease. Arch. Neurol. 42:1985;50-54.
108. Weinreb H. J. Dermatoglyphic patterns in Alzheimer's disease. J. Neurogenet. 3:1986;233-246.
109. Wijsman E. M. Genetic analysis of Alzheimer's disease: A summary of contributions to GAW 8. Genet. Epidemiol. 10:1993;349-360.
110. Yatham L. N., McHale P. A., Kinsella A. Down's syndrome and its association with Alzheimer's disease. Acta Psychiatr. Scand. 77:1988;38-41.
111. Yoon P. W., Freeman S. B., Sherman S. L., Taft L. F., Gu Y., Pettay D., Flanders W. D., Khoury M. J., Hassold T. J. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: A population-based study. Am. J. Hum. Genet. 58:1996;628-633.
112. Zigman W. B., Schupf N., Sersen E., Silverman W. Prevalence of dementia in adults with and without Down syndrome. Am. J. Ment. Retard. 100:1996;403-412.
113. Zittergruen M. M., Murray J. C., Lauer R. M., Burns T. L., Sheffield V. C. Molecular analysis of nondisjunction in Down syndrome patients with and without atrioventricular septal defects. Circulation. 92:1995;2803-2810.